Raymond James Financial
TLSA icon

Raymond James Financial’s Tiziana Life Sciences TLSA Stock Holding History

Raymond James Financial’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$790 – 6622
2025
Q2 		$790 Buy
+500
New +$668 ﹤0.01% 6607
2025
Q1 		– Sell
-10,000
Closed -$6.96K – 4952
2024
Q4 		$6.96K Buy
+10,000
New +$9.25K ﹤0.01% 4782

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Raymond James Financial's TLSA Position: Q3 2025 in Review

Raymond James Financial sold out of Tiziana Life Sciences (TLSA) in Q3 2025, closing a stake of 500 shares — an estimated $790 sold.

Raymond James Financial first reported a position in TLSA in Q4 2024 and held it in 2 quarters. The position peaked at $6.96K in Q4 2024. 31 funds tracked by Wall St. Rank hold TLSA as of Q3 2025.

  • Raymond James Financial reported no remaining Tiziana Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 500 Tiziana Life Sciences shares in Q3 2025, an estimated $790.
  • Raymond James Financial first reported a position in Tiziana Life Sciences in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's Tiziana Life Sciences position peaked at $6.96K in Q4 2024.
  • 31 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.